01 3Bristol-Myers Squibb Pharmaceutical Group (Div. Of Bristol-Myers Squibb Can. Inc.)
02 5Gilead Sciences Canada Inc.
01 41338670
02 11340253
03 12433280
04 12530774
05 12708703
01 8Aztreonam
01 5 POWDER FOR SOLUTION
02 3Powder
01 42013-10-22
02 12015-12-15
03 22021-12-20
04 12024-07-01
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Brand Name : AZACTAM
Patent Number : 1338670
Filing Date :
Strength per Unit : 2 gr/ vial
Dosage Form : Powder
Human Or VET : Human
Route of Administration : parenteral
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Brand Name : AZACTAM
Patent Number : 1338670
Filing Date :
Strength per Unit : 1 gr
Dosage Form : Powder
Human Or VET : Human
Route of Administration : parenteral
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Brand Name : AZACTAM
Patent Number : 1338670
Filing Date :
Strength per Unit : 500 mg/vial
Dosage Form : Powder
Human Or VET : Human
Route of Administration : parenteral
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Patent Expiration Date : 2015-12-15
Date Granted : 1998-12-15
Brand Name : CAYSTON
Patent Number : 1340253
Filing Date : 1981-02-06
Strength per Unit : 75 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2015-12-15
Date Granted : 1998-12-15
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Brand Name : CAYSTON
Patent Number : 1338670
Filing Date : 1981-02-06
Strength per Unit : 75 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2013-10-22
Date Granted : 1996-10-22
Patent Expiration Date : 2021-12-20
Date Granted : 2012-12-04
Brand Name : CAYSTON
Patent Number : 2708703
Filing Date : 2001-12-20
Strength per Unit : 75 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2021-12-20
Date Granted : 2012-12-04
Patent Expiration Date : 2024-07-01
Date Granted : 2011-10-18
Brand Name : CAYSTON
Patent Number : 2530774
Filing Date : 2004-07-01
Strength per Unit : 75 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2024-07-01
Date Granted : 2011-10-18
Patent Expiration Date : 2021-12-20
Date Granted : 2010-09-21
Brand Name : CAYSTON
Patent Number : 2433280
Filing Date : 2001-12-20
Strength per Unit : 75 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2021-12-20
Date Granted : 2010-09-21
